Xvivo Perfusion ABXVIPF -1.32%91 Operating Margin % is 13.26% as of Mar. 2026, which is 528% above its 10-year median of 2.11. GuruFocus rates XVIPF with a GF Score™ of 91/100 and a GF Value™ of $42.07 (Significantly Undervalued). The stock has 2 warning signs investors should review. Among 816 Medical Devices & Instruments companies, Xvivo Perfusion AB ranks better than 68.75% on this metric.
The historical rank and industry rank for Xvivo Perfusion AB's Operating Margin % or its related term are showing as below:
XVIPF'
s Operating Margin % Range Over the Past 10 Years
Min: -24.57 Med: 2.11 Max: 11.34
Current: 11.23
XVIPF's Operating Margin % is ranked better than 68.75% of 816
companies
in the Medical Devices & Instruments industry
Industry Median: 3.465
vs XVIPF: 11.23
Xvivo Perfusion AB's 5-Year Average Operating Margin % Growth Rate was 0.00% per year.
Xvivo Perfusion AB (OTCPK:XVIPF) Operating Margin % Explanation
Just like Gross Margin %, it is important to see a company maintains its operating margin over time. Among the same industry, a company with higher operating margin is more efficient in its operation. It is also more stable during industry slowdown or recessions. Peter Lynch prefers those with higher margins than those with lower margins.
Be Aware
Operating Margin % can be manipulated by adjusting the rate of depreciation, depletion and amortization (DDA).
If a company is facing competition, its Operating Margin % may decline. Often the Operating Margin % declines well before the company's Revenue or even profit decline. Therefore, Operating Margin % is a very important indicator of whether the company is facing problems.
For instance, by 2012, Nokia (NOK)'s problems were well known and its stock had lost more than 90% of its market value since 2007. But Nokias Operating Margin % had already been in decline since 2002, although its Earnings per Share (Diluted) were still rising. Investors who paid attention to Operating Margin % would have avoided this huge loss. The same can be said for Research-in-Motion (RIMM).
Therefore, Operating Margin % is a very important screening filter for GuruFocus. GuruFocus's Buffett-Munger screener requires that the profit margin is either consistent or expanding. The Model Portfolio of the Buffett-Munger screener has outperformed the market every year since inception in 2009.
Xvivo Perfusion AB Operating Margin % Related Terms
Xvivo Perfusion AB Operating Margin % Historical Data
* Premium members only.
The historical data trend for Xvivo Perfusion AB's Operating Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
XVIPF vs ABT, SYK, MDT: Operating Margin % Comparison
For the Medical Devices subindustry, Xvivo Perfusion AB's Operating Margin %, along with its competitors' market caps and Operating Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Xvivo Perfusion AB Operating Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Xvivo Perfusion AB's Operating Margin % distribution charts can be found below:
* The bar in red indicates where Xvivo Perfusion AB's Operating Margin % falls into.
Operating Margin % - also known as operating income margin, operating profit margin and return on sales (ROS) - is the ratio of Operating Income divided by net sales or Revenue, usually presented in percent.
Xvivo Perfusion AB's Operating Margin % for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Xvivo Perfusion AB (XVIPF) has a Operating Margin % of 13.26% as of Mar. 2026. Operating margin is the ratio of total operating income to net sales. View historical data on Xvivo Perfusion AB and its competitors. This is 528% above median its historical median of 2.11. According to the industry distribution chart, Xvivo Perfusion AB ranks #255 out of 816 companies in the Medical Devices & Instruments industry, placing it in the top 31.2%.
Is Xvivo Perfusion AB's Operating Margin % too high?
Xvivo Perfusion AB's current Operating Margin % of 13.26% is 528% above median its 10-year median of 2.11. The Medical Devices & Instruments industry median Operating Margin % is 3.47. Xvivo Perfusion AB's value of 13.26% is 282.7% above this industry median. Based on the distribution chart, Xvivo Perfusion AB ranks #255 out of 816 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Xvivo Perfusion AB has a GF Score™ of 91/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Xvivo Perfusion AB's Operating Margin % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Xvivo Perfusion AB ranks #255 out of 816 companies for Operating Margin %. This puts Xvivo Perfusion AB in the upper half of its industry. The industry median Operating Margin % is 3.47. Xvivo Perfusion AB's value of 13.26% is 282.7% above this benchmark. While the company's 10-year median is 2.11 vs. the industry median of 3.47, Xvivo Perfusion AB has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Operating Margin % for a Medical Devices & Instruments company?
The median Operating Margin % among Medical Devices & Instruments companies is 3.47, based on 816 companies in the industry. Companies in the top quartile (top 25%) have a Operating Margin % significantly above this median, while those in the bottom quartile fall well below. However, Operating Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Xvivo Perfusion AB's current Operating Margin % of 13.26% is 282.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Operating Margin % mean?
A high Operating Margin % can signal that a stock is expensive relative to its fundamentals. Operating margin is the ratio of total operating income to net sales. View historical data on Xvivo Perfusion AB and its competitors. For the Medical Devices & Instruments industry, the median Operating Margin % is 3.47 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Xvivo Perfusion AB's current Operating Margin % is 13.26%, which is 528% above median its own 10-year median of 2.11. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Xvivo Perfusion AB stock overvalued right now?
Based on GuruFocus' analysis, Xvivo Perfusion AB (XVIPF) is currently considered Significantly Undervalued. The stock's GF Value™ is $42.07, compared to a current price of $29.00 — trading 31.1% below its estimated fair value. The current Operating Margin % is 13.26%, which is 528% above median its 10-year median of 2.11 and 282.7% above the Medical Devices & Instruments industry median of 3.47. Xvivo Perfusion AB's overall GF Score™ is 91/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Operating Margin % calculated?
Operating Margin % is calculated from a company's financial statements. For Xvivo Perfusion AB (XVIPF), the current Operating Margin % is 13.26% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Xvivo Perfusion AB (XVIPF) Overvalued in 2026?
Based on GuruFocus' analysis, Xvivo Perfusion AB stock appears to be undervalued.
The current stock price of $29.00 is trading 31.1% below its estimated GF Value™ of $42.07.
GuruFocus considers Xvivo Perfusion AB to be Significantly Undervalued.
Key valuation signals for XVIPF:
Operating Margin %: 13.26% (528% above median its 10-year median of 2.11)
GF Value™: $42.07 vs. price of $29.00 (31.1% below fair value)
Industry Position: 282.7% above the Medical Devices & Instruments median (#255 of 816)
No single metric tells the full story. See the XVIPF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Xvivo Perfusion AB is a medical technology company dedicated to extending the life of organs so transplant teams around the world can save more lives. Its solutions allow clinicians and researchers to push the boundaries of transplantation medicine. It operates in three segments, namely Thoracic: sales of lung and heart transplant products; Abdominal: sales of liver and kidney transplant products and perfusion services; and Services: revenue from the sale of services related to organ recovery, as well as digital products for communication and workflow management at transplantation clinics. The majority of revenue is derived from the Thoracic segment, and geographically, the majority is from the United States.
91GF Score
Get the complete analysis for XVIPF
Operating Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XVIPF has been successfully added to your 
